top of page

PUBLICATIONS & PATENTS

PUBLICATIONS (^: co-first author, *: corresponding author)

  • 47. Jo K, Linh VTN, Yang JY, Heo B, Kim JY, Mun NE, Im JH, Kim KS, Park SG, Lee MY, Yoo SW*, Jung HS*. Machine learning-assisted label-free colorectal cancer diagnosis using plasmonic needle-endoscopy system. Biosensors and Bioelectronics. 2024:116633
     

  • 46. Song GY, Jung SH, Ahn SY, Kim M, Ahn JS, Lee JJ, Kim HJ, Moon JB, Yoo SW, Kwon SY, Min JJ, Bom HS, Kang SR, Yang DH. Prognostic significance of sequential 18F-FDG PET/CT during frontline treatment of peripheral T cell lymphomas. Korean J Intern Med. 2024;39(2):327-337.
     

  • 45. Mun NE, Tran TKC, Park DH, Im JH, Park JI, Le TD, Moon YJ, Kwon SY, and Yoo SW. Endoscopic hyperspectral imaging system to discriminate tissue characteristics in tissue phantom and orthotopic mouse pancreatic tumor model. Bioengineering 2024;11:208.
     

  • 44. Yoo SW, Kwon SY, Kang SR, Min JJ. Molecular imaging approaches to facilitate bacteria-mediated cancer therapy. Advance Drug Delivery Reviews 2022;187:114366.
     

  • 43. Park KS, Seon HJ, Yun JS, Yoo SW, Lee CH, Kang SR, Kim J, Cho SG, Song HC, Bom HS, Min JJ, Kwon SY. Precise characterization of a solitary pulmonary nodule using tumor shadow disappearance rate-corrected F-18 FDG PET and enhanced CT. Medicine (Baltimore) 2022;101(5):e28764.
     

  • 42. Kang SR, Nguyen DH, Yoo SW, Min JJ. Bacteria and bacterial derivatives as delivery carriers for immunotherapy. Advance Drug Delivery Reviews 2021;181:114085.
     

  • 41. Moon JB^, Yoo SW^, Lee C, Kim DY, Pyo A, Kwon SY. Multimodal imaging-based potential visualization of the tumor microenvironment in bone metastasis. Cells 2021, 10(11):2877.
     

  • 40. Jeong S, Yoo SW, Kim HJ, Park J, Kim JW, Lee C, Kim H. Recent Progress on Molecular Photoacoustic Imaging with Carbon-Based Nanocomposites. Materials 2021;14(19):5643.
     

  • 39. Kwon SY, Kim MH, Kong E, Chong A, Yoo SW, Jeon S, Park SA, Kim DW, Kang SH, Choi JE, Ha JM, Jeong SY, Lee SW. Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study. Clin Endocrinol (Oxf). 2021;95(6):901-908.
     

  • 38. Moon JB, Jeon S, Park KS, Yoo SW, Kang SR, Cho SG, Kim J, Lee C, Song HC, Min JJ, Bom HS, Kwon SY. Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin-Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma. Nucl Med Mol Imaging. 2021 Jun;55(3):116-122.
     

  • 37. Moon JB, Cho SG, Yoo SW, Bom HH. Increasing Use of Cardiac PET/CT for Inflammatory and Infiltrative Heart Diseases in Korea. Chonnam Med J. 2021 May;57(2):139-143.
     

  • 36. Piao HH, Jeon S, Yoo SW, Ryu YJ, Kim DY, Pyo A, Bom HS, Min JJ, Kwon SY. A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [18F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer. Diagnostics (Basel). 2021 May 6;11(5):836.
     

  • 35. Mai TT^, Yoo SW^, Park S, Kim JY, Choi KH, Kim C, Kwon SY, Min JJ, Lee C. In Vivo Quantitative Vasculature Segmentation and Assessment for Photodynamic Therapy Process Monitoring Using Photoacoustic Microscopy. Sensors 2021, 21(5), 1776.
     

  • 34. Yoo SW, Kim DY, Pyo A, Jeon S, Kim J, Kang SR, Cho SG, Lee C, Kim GJ, Song HC, Bom HS, Min JJ, Kwon SY. Differences in diagnostic impact of dual-tracer PET/computed tomography according to the extrahepatic metastatic site in patients with hepatocellular carcinoma. Nucl Med Commun. 2021 Feb 19. doi: 10.1097/MNM.0000000000001382. 
     

  • 33. Yoo SW^, Oh G^, Ahn JC, Chung E. Non-Oncologic Applications of Nanomedicine-Based Phototherapy. Biomedicines. 2021;9(2):113.
     

  • 32. Yoo SW^, Chowdhury MSA^, Jeon S, Kang SR, Lee C, Jabin Z, Kim J, Cho SG, Song HC, Bom HS, Min JJ, Kwon SY. Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site. Nucl Med Mol Imaging. 2020;54(4):192-198.
     

  • 31. Kim MS, Park HY, Kho BG, Park CK, Oh IJ, Kim YC, Kim S, Yun JS, Song SY, Na KJ, Jeong JU, Yoon MS, Ahn SJ, Yoo SW, Kang SR, Kwon SY, Bom HS, Jang WY, Kim IY, Lee JE, Jeong WG, Kim YH, Lee T, Choi YD. Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board. Transl Lung Cancer Res. 2020;9(3):507-514.
     

  • 30. Jeon S, Kwon SY, Ryu YJ, Kang SR, Yoo SW, Cho SG, Kim J, Song HC, Sohn SJ, Bom HS, Min JJ. Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma. Nucl Med Commun. 2020;41(8):733-739.
     

  • 29. Mutsuddy P, Jeon S, Yoo SW, Zhang Y, Chowdhury MSA, Kim J, Song HC, Bom HS, Min JJ, Kwon SY. Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients. Medicine (Baltimore). 2020;99(14):e19652.
     

  • 28. Yoo SW, Nguyen DH, Park SH, Lee H, Lee CM, Lee C, Min JJ. Development of Dual-Scale Fluorescence Endoscopy for In Vivo Bacteria Imaging in an Orthotopic Mouse Colon Tumor Model. Appl. Sci. 2020, 10(3), 844
     

  • 27. Yoo SW^, Chowdhury MSA^, Jeon S, Kang SR, Cho SG, Kim J, Lee C, Ryu YJ, Song HC, Bom HS, Min JJ, Kwon SY. Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma. Cancers (Basel). 2020;12(2). 
     

  • 26. Kim HK, Yoon JH, Cho JS, Kwon SY, Yoo SW, Kang HC. The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer. Korean J Intern Med. 2019 Jul 29. doi: 10.3904/kjim.2018.173.
     

  • 25. Cho SG, Kwon SY, Kim J, Cho DH, Na MH, Kang SR, Yoo SW, Song HC. Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy. Medicine (Baltimore). 2019;98(16):e14858. 
     

  • 24. Kim J, Cho SG, Kang SR, Yoo SW, Kwon SY, Min JJ, Bom HS, Song HC. Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity. J Nucl Cardiol. 2019 Feb 4. doi: 10.1007/s12350-019-01617-y.
     

  • 23. Kim J, Choi KH, Cho SG, Kang SR, Yoo SW, Kwon SY, Min JJ, Bom HS, Song HC. Association of muscle and visceral adipose tissues with the probability of Alzheimer's disease in healthy subjects. Sci Rep. 2019;9(1):949.
     

  • 22. Bae SM, Bae DJ, Do EJ, Oh G, Yoo SW, Lee GJ, FChae JS, Yun Y, Kim S, Kim KH, Chung E, Kim JK, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Yang SK, Joo J, Kim SY, Myung SJ. Multi-Spectral Fluorescence Imaging of Colon Dysplasia InVivo Using a Multi-Spectral Endoscopy System. Transl Oncol. 2018;12(2):226-235.
     

  • 21. Yoo SW, Jung D, Min JJ, Kim H, Lee C. Biodegradable Contrast Agents for Photoacoustic Imaging. Appl. Sci. 2018, 8(9), 1567.
     

  • 20. Song M, Jeon S, Kang SR, Jabin Z, Yoo SW, Min JJ, Bom HS, Cho SG, Kim J, Song HC, Kwon SY. Response Prediction of Altered Thyroglobulin Levels After Radioactive Iodine Therapy Aided by Recombinant Human Thyrotropin in Patients with Differentiated Thyroid Cancer. Nucl Med Mol Imaging. 2018;52(4):287-292.
     

  • 19. Ahn SY, Kwon SY, Jung SH, Ahn JS, Yoo SW, Min JJ, Bom HS, Ki SY, Kim HJ, Lee JJ, Song SY, Yang DH. Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma. Clin Nucl Med. 2018;43(8):e259-e264.
     

  • 18. Yoo SW, Oh G, Safi AM, Hwang S, Seo YS, Lee KH, Kim YL, Chung E. Endoscopic non-ablative fractional laser therapy in an orthotopic colon tumour model. Sci Rep. 2018;8:1673.
     

  • 17. Yoo SW, Kim DY, Lee C, Min JJ, Kwon SY. Small Bowel Metastasis From Hepatocellular Carcinoma Detected by 18F-FDG PET/CT But Not by 11C-Acetate PET/CT. Clin Nucl Med. 2017;42(12):966-967.
     

  • 16. Yun M, Kim DY, Lee JJ, Kim HS, Kim HS, Pyo A, Ryu Y, Kim TY, Zheng JH, Yoo SW, Hyun H, Oh G, Jeong J, Moon M, Min JH, Kwon SY, Kim JY, Chung E, Hong Y, Lee W, Kim HS, Min JJ. A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors. Theranostics. 2017;7(10):2620-2633.
     

  • 15. Le VH^, Yoo SW^, Yoon Y, Wang T, Kim B, Lee S, Lee KH, Kim KH, Chung E. Brain tumor delineation enhanced by moxifloxacin-based two-photon/CARS combined microscopy. Biomed Opt Express, 2017:8(4):2148-2161.
     

  • 14. Yoo SW, Park HJ, Oh G, Hwang S, Yun M, Seo YS, Min JJ, Kim ES, Kim YL, Chung E. Non-ablative fractional thulium laser irradiation suppresses early tumor growth. Current Optics and Photonics 2017: 1(1): 60-64.
     

  • 13. Oh G, Park Y, Yoo SW, Hwang S, Chin-Yu AVD, Ryu Y, Kim SY, Do EJ, Kim KH, Kim S, Myung SJ, Chung E. Clinical compatible flexible wide-field multi-color fluorescence endoscopy with a porcine colon model. Biomed Opt Express, 2017:8(2):764-775.
     

  • 12. Park HJ, Jeong GC, Kwon SY, Min JJ, Bom HS, Park KS, Cho SG, Kang SR, Kim J, Song HC, Chong A, Yoo SW. Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma. Nucl Med Mol Imaging 2014: 48:255–261.
     

  • 11. Oh G, Yoo SW, Jung Y, Ryu YM, Park Y, Kim SY, Kim KH, Kim SJ, Myung SJ, Chung E. Intravital imaging of mouse colonic adenoma using MMP-based molecular probes with multi-channel fluorescence endoscopy. Biomed Opt Express, 2014:5(5):1677-1689.
     

  • 10. Kim J, Yoo SW, Kang SR, Bom HS, Song HC, Min JJ. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann Hematol. 2014:93(4):661-7.
     

  • 9. Byun BH, Kwon SY, Chong A, Kim JH, Yoo SW, Min JJ, Song HC, Bom HS. Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer. Asia Oceania J Nucl Med Biol. 2013:1(1):6-13.
     

  • 8. Yoo SW, Kim J, Chong A, Kwon SY, Min JJ, Song HC, Bom HS. Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer. Nucl Med Mol Imaging. 2012:46(4) 286-293.
     

  • 7. Kim J, Yoo SW, Kang SR, Cho SG, Oh JR, Chong A, Min JJ, Bom HS, Yoon JH, Song HC. Prognostic Significance of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Operable Primary Breast Cancer. Nucl Med Mol Imaging. 2012:46(4) 278-285.
     

  • 6. Yoon MS, Ahn SJ, Nah BS, Chung WK, Song HC, Yoo SW, Song JY, Jeong JU, Nam TK. Metabolic Response of Lymph Nodes Immediately After RT Is Related With Survival Outcome of Patients With Pelvic Node-Positive Cervical Cancer Using Consecutive [(18)F] fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2012:84(4) e497-497.
     

  • 5. Yoo SW, Song HC, Oh JR, Kim J, Kang SR, Chong A, Byun BH, Hong SP, Min JJ, Bom HS. Herniation Pit Mimicking Osseous Metastasis on 18F-FDG PET/CT in Patient With Lung Cancer. Clin Nucl Med. 2012:37 682-683.
     

  • 4. Oh JR, Byun BH, Hong SP, Chong A, Kim J, Yoo SW, Kang SR, Kim DY, Song HC, Bom HS, Min JJ. Comparison of 131I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/CT in the detection of metastatic thyroid cancer. Eur J Nucl Med Mol Imaging. 2011:38 1459-1468.
     

  • 3. Oh JR, Song HC, Kang SR, Yoo SW, Kim J, Chong A, Min JJ, Lee SS, Park YW. The Clinical Usefulness of18F-FDG PET/CT in Patients with Systemic Autoimmune Disease. Nucl Med Mol Imaging. 2011:45(3) 177-184.
     

  • 2. Chong AR, Song HC, Min JJ, Jeong SY, Ha JM, Kim JH, Yoo SU, Oh JR, Bom HS. Improved Detection of Lung or Bone Metastases with an I-131 Whole Body Scan on the 7th Day After High-Dose I-131 Therapy in Patients with Thyroid Cancer. Nucl Med Mol Imaging. 2010:44(4) 273-281.
     

  • 1. Kim J, Song HC, Yoo SW, Ha JM, Jung A, Oh JR, Min JJ, Bom HS, Jeong EH, Lee MC. Juvenile Dermatomyositis Diagnosed by 99mTc-HDP Three-phase Bone Scintigraphy. Nucl Med Mol Imaging. 2009:43(6) 592-595.

PATENTS

  • Chung E, Oh G, Hwang S, Yoo SW. Endoscope Device for Detecting Disease based on Thermal Images. (Domestic Registration No. 1018524390000)

  • Kim H, Jung D, Lee K, Yoo SW. Selective de-cross-linking of transformable double-network hydrogel and fabricating method there of (Domestic Application No. 1020180111085 )

PROCEEDING

  • 3. Le TD, Yoo SW, Lee C. Improving prostate cancer diagnosis with synthetic SPECT images using semi-supervised generative adversarial network. Proc. SPIE PC12834, Multimodal Biomedical Imaging XIX, PC128340M (13 March 2024); https://doi.org/10.1117/12.3002189
     

  • 2. Yoo SW, Kim HS, Min JJ, Lee C. In vivo monitoring of theranostic fluorescence bacteria in orthotopic colon cancer model with multiscale fluorescence endoscopy. Proc. SPIE 10854, Endoscopic Microscopy XIV, 108541E (26 February 2019); doi:10.1117/12.2509530 
     

  • 1. Yoo SW, Mun H, Oh G, Ryu Y, Kim MG, Chung E. Light Shift from Ultraviolet to Near Infrared Light: Cerenkov Luminescence with Gold Nanocluster – Near Infrared (AuNc-NIR) Conjugates. Proc. SPIE 9328, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XIII, 93280C (March 2, 2015); doi:10.1117/12.2080898

bottom of page